×
ADVERTISEMENT

FEBRUARY 18, 2025

Follow the Yellow Brick Road for Biosimilars Savings

By Gina Shaw

With 41 biosimilars launched for 11 branded reference products, and at least 10 more expected to enter the market in 2025—plus dozens of others in the pipeline—pharmacies need a standardized approach for adding new biosimilars to their formularies, an expert noted during the 2024 NASP Annual Meeting & Expo, in Nashville, Tenn.

Sarah Yelenich, PharmD, CSP, a clinical services manager at the University of Arkansas for Medical Sciences Specialty Pharmacy, in Little Rock,